Document Detail


Injectable contraception (medroxyprogesterone acetate) in rural Bangladesh.
MedLine Citation:
PMID:  72288     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1601 women used the injectable contraceptive agent medroxyprogesterone acetate for up to 3 years. The programme was conducted by a rural health centre with detailed follow-up. While the continuation-rate, 56% after 1 year, compared favourably with that of other contraceptive methods in Bangladesh, at least half the women experienced troublesome menstrual side-effects and there were indications that milk yield was adversely affected in 147 out of the 1020 women who received the first injection while lactating.
Authors:
L Parveen; A Q Chowdhury; Z Chowdhury
Related Documents :
12295178 - Choice and changes of contraceptive methods after primiparous delivery in shanghai.
3314398 - Studies of quinacrine and of tetracycline for non-surgical female sterilization.
19521578 - Catching up on contraception.
22359978 - Effect of short-term standard therapeutic regimens on neuropeptide y and adipose tissue...
23138498 - Statins may reduce femoral osteolysis in patients with total hip arthroplasty.
17485798 - Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Lancet     Volume:  2     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1977 Nov 
Date Detail:
Created Date:  1977-12-29     Completed Date:  1977-12-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  946-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bangladesh
Contraceptive Agents, Female / administration & dosage*
Drug Evaluation
Female
Follow-Up Studies
Health Knowledge, Attitudes, Practice
Humans
Injections, Intramuscular
Lactation / drug effects
Medroxyprogesterone / administration & dosage*,  adverse effects
Menstruation / drug effects
Menstruation Disturbances / chemically induced
Patient Dropouts
Pregnancy
Rural Population*
Chemical
Reg. No./Substance:
0/Contraceptive Agents, Female; 520-85-4/Medroxyprogesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blood viscosity, red-cell flexibility, haematocrit, and plasma-fibrinogen in patients with angina.
Next Document:  Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microg...